TEMECULA, CA -- (MARKET WIRE) -- September 19, 2006 -- CLX Investment Company, Inc. (OTCBB: CLXN), a diversified investment fund with holdings in e-learning, global advertising and diagnostic testing markets, today announced that portfolio investment Zonda Incorporated has entered into a distribution agreement to introduce its HandiLab-C test for chlamydia in Turkey.
